Acute kidney injury in multiple myeloma patients undergoing autologous hematopoietic stem cell transplant: a cohort study
Open Access
- 29 November 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal Of Nephrology
- Vol. 37 (2) , 419-428
Abstract
Background Autologous hematopoietic stem cell transplant plays an important role in multiple myeloma (MM) treatment. Increasing incidence of MM and growing awareness of acute kidney injury (AKI) as a complication of hematopoietic stem cell transplant results in the need to better understand AKI in these patients. We aimed to evaluate incidence, risk factors and 5-year prognostic impact of AKI in MM patients undergoing autologous hematopoietic stem cell transplant. Methods Retrospective cohort study. AKI was defined by the KDIGO classification using creatinine and urinary output criteria. We used survival analysis methods considering competing events for risk factors and disease-free survival, Cox proportional regression for overall survival and stepwise regression methods for multivariable models. Results We analyzed data regarding 143 patients. The cumulative incidence of AKI and moderate-to-severe AKI was 49.7% and 14.1%, respectively. Factors with independent impact on AKI were obesity (HR: 1.83, 95% CI 1.07–3.11; p = 0.026), Hematopoietic cell transplantation—specific comorbidity index (HCT-CI) ≥ 2 (HR: 1.85, 95% CI 1.08–3.17), chronic kidney disease (CKD) (HR: 2.06, 95% CI 1.05–4.04), amyloidosis (HR: 2.25, 95% CI 1.25–4.06), mucositis grade 3–4 (HR: 2.19, 95% CI 1.25–3.86) and exposure to nephrotoxic drugs (HR: 2.0856, 95% CI 1.04–4.19). Moderate-to-severe AKI had an impact (HR: 1.62, 95% CI 1.15–2.31) on 5-year overall survival. Conclusion Acute kidney injury affects almost half of MM patients undergoing autologous hematopoietic stem cell transplantation, and reduction in urinary output allows early diagnosis in almost a quarter of the patients. Obesity, HCT-CI ≥ 2, CKD, amyloidosis, mucositis grade 3–4 and exposure to nephrotoxic drugs are significant risk factors. Moderate-to-severe AKI is associated with lower 5-year overall survival. Graphical abstractKeywords
Funding Information
- Universidade de Lisboa
- Universidade de Lisboa
This publication has 28 references indexed in Scilit:
- Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow TransplantationBone Marrow Transplantation, 2013
- Obesity and Oxidative Stress Predict AKI after Cardiac SurgeryJournal of the American Society of Nephrology, 2012
- Ensuring accurate oral mucositis assessment in the European Group for Blood and Marrow Transplantation Prospective Oral Mucositis AuditEuropean Journal of Oncology Nursing, 2007
- Early renal injury after myeloablative allogeneic and autologous hematopoietic cell transplantationBone Marrow Transplantation, 2006
- Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCTBlood, 2005
- Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)Kidney International, 2005
- International Staging System for Multiple MyelomaJournal of Clinical Oncology, 2005
- Incidence and outcome of acute renal failure complicating autologous stem cell transplantation for AL amyloidosisKidney International, 2003
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- Renal function in high dose chemotherapy and autologous hematopoietic cell support treatment for breast cancerKidney International, 1996